QSI PHARMA A/S: Financial statements 2012
CVR: 26444071
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
QSI PHARMA A/S (CVR 26444071) has filed annual accounts for 2012. In 2012, the company reported a net result of DKK 170,000. Equity in the 2012 report amounted to DKK 26,264,000. The solvency ratio was 99.7%.
- Profit/Loss
- DKK 170,000
- Equity
- DKK 26,264,000
- Total Assets
- DKK 26,346,000
Official annual report
Keep an eye on QSI PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of December 18, 2012, Lars Olsen has joined the board of directors of QSI PHARMA A/S.
As of December 18, 2012, Tore Duvold has left the board of directors of QSI PHARMA A/S.
As of December 18, 2012, Kristian Merser is registered as chairman of QSI PHARMA A/S.
As of December 18, 2012, Peter Møller Nielsen has stepped down as chairman of QSI PHARMA A/S.
About QSI PHARMA A/S
QSI PHARMA A/S was a Danish company of the type Aktieselskab based in Ballerup, founded in 2002. The company has been dissolved on 20 August 2013. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 8 employees (2004). In 2012, the company reported a net result of DKK 170,000. Equity in the 2012 report amounted to DKK 26,264,000.